TITLE:
Contribution of Musculoskeletal Disorders to Chronic Lumbago in Parkinson’s Disease
AUTHORS:
Makoto Shiraishi, Kensuke Shinohara, Masashi Akamatsu, Yasuhiro Hasegawa
KEYWORDS:
Chronic Lumbago, Parkinson’s Disease, Bone Mineral Metabolism, 1, 25-(OH)2-Vitamin D
JOURNAL NAME:
Advances in Parkinson's Disease,
Vol.5 No.3,
August
11,
2016
ABSTRACT: Purpose: To clarify the impact of bone metabolism disorder on lumbago in Parkinson’s Disease
(PD). Methods: Data was retrospectively analyzed from 52 patients with PD in our outpatient clinic
for more than 1 year (mean age, 63 ± 4 years old; mean duration from onset, 6.3 ± 0.8 years).
Patients’ characteristics, comorbid musculoskeletal disorders, serum bone metabolism biomarkers,
and bone mineral density were examined. Results: Twenty-one PD patients (40.2%) had
chronic lumbago. Severe comptocormia and scoliosis were the most common musculosketal disorders
in this group (47.6%) affected by lumbago, followed by osteoporosis (14.3%), compression
fracture (4.8%). There was no significant difference in the duration of PD, body mass index, frequency
of falls, bone mineral density, tartrate-resistant acid phosphatase-5b, osteocalcin, and
N-terminal telopeptide between PD patients with or without chronic lumbago. Multivaritae logistic
regression analysis identified the independent predictors of chroni lumbago in PD patients as
Hoen-Yahr stage (odds ration [OR] = 2.794, 95%CI 1.103 - 7.076), and elevated serum 1,25-OH2 vitamin D level ([OR] = 0.92, 95%CI 0.86 - 98). Conclusion: Bone metabolism disorders are found
to be associated with chronic lumbago in PD patients.